Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Peripher Nerv Syst ; 26(1): 113-117, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33320396

ABSTRACT

We report the case of a patient with a clinical phenotype characterized by distal lower limb weakness and pes cavus. The electrophysiological study showed slightly reduced or normal amplitude of motor potentials, a decremental response to repetitive nerve stimulation and post-exercise facilitation. Muscle biopsy showed only mild neurogenic features. Genetic analysis included a clinical exome sequencing, followed by Sanger analysis. Three-dimensional (3D) models were generated with a SwissModel (https://swissmodel.expasy.org/) to explain the clinical observations and reinforce the pathogenic nature of the genetic variant identified. Genetic analysis demonstrated a new de novo heterozygous in frame deletion of the SYT2 gene (NM_177402.4: c.1082_1096del), confirmed by Sanger sequencing, which removes five aminoacids in the C2B domain of synaptotagmin-2 protein, that cause a profound effect on the structure and function of this synaptic vesicle protein. We identified a de novo genetic variant in the SYT2 gene, further supporting its association with a highly stereotyped clinical and electrophysiological phenotype. Our case showed electrophysiological features consistent with a presynaptic dysfunction in the neuromuscular junction with normal post-exercise amplitudes, not supporting the presence of predominant axonal damage. Although the analysis of SYT2 gene should be included in genetic analysis of patients presenting with this clinical phenotype that mimics motor neuropathy, clinicians have to consider the study of neuromuscular transmission to early identify this potentially treatable condition.


Subject(s)
Muscle Weakness/physiopathology , Neuromuscular Diseases/diagnosis , Neuromuscular Junction/physiopathology , Peripheral Nervous System Diseases/diagnosis , Synaptotagmin II/genetics , Adult , Electrodiagnosis , Frameshift Mutation , Humans , Lower Extremity/physiopathology , Male , Neuromuscular Diseases/genetics , Neuromuscular Diseases/physiopathology , Pedigree , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/physiopathology
2.
Hemoglobin ; 44(4): 294-296, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32693657

ABSTRACT

Here we report a Spanish family in which two members, mother and daughter, present with a phenotype of mild non transfusion-dependent thalassemia (NTDT) due to compound heterozygosity for δß-thalassemia (δß-thal) and the α gene triplication ααα-3.7. They carry the most prevalent form of δß-thal in Spain, the so-called Spanish δß0-thal, which consists of a deletion of 114 kb that affects the δ and ß genes. A mild microcytic anemia [hemoglobin (Hb) 10.6 g/dL and mean corpuscular volume (MCV) 72.8 fL, and Hb 10.9 g/dL and MCV 70.0 fL, respectively], hypocromia [mean corpuscular Hb (MCH), 23.4 and 22.6 pg, respectively], increased red blood cell (RBC) distribution width (RDW) (20.0 and 21.9%, respectively), high fetal Hb (Hb F) (23.7 and 21.6%, respectively) with Hb A2 within the normal range, and splenomegaly, were present in the affected subjects. In areas were δß-thal is prevalent, the interaction with triplicated α-globin genes should be suspected in cases of mild NTDT if Hb F is high and Hb A2 is not increased.


Subject(s)
Mutation , alpha-Globins/genetics , beta-Thalassemia/diagnosis , beta-Thalassemia/genetics , Adolescent , Adult , Aged , Alleles , DNA Mutational Analysis , Erythrocyte Indices , Female , Genotype , Hemoglobins, Abnormal/genetics , Humans , Male , Middle Aged , Pedigree , Phenotype , Spain , beta-Globins/genetics , beta-Thalassemia/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...